| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.00062 | 1 |